14.43
Beta Bionics Inc Borsa (BBNX) Ultime notizie
Is Beta Bionics Inc. a good long term investmentStrongest growth potential - Autocar Professional
What analysts say about Beta Bionics Inc. stockRobust financial gains - Autocar Professional
What drives Beta Bionics Inc. stock priceExceptional profit velocity - Autocar Professional
Beta Bionics Inc. Stock Analysis and ForecastTriple-digit return opportunities - Autocar Professional
Beta Bionics, Inc.’s Lock-Up Period Will Expire on July 29th (NASDAQ:BBNX) - Defense World
Is Sprinklr Inc. a good long term investmentConsistent triple returns - jammulinksnews.com
Editas Medicine Inc. Stock Analysis and ForecastExponential wealth increase - jammulinksnews.com
NIP Group Inc. Depositary Receipt Stock Analysis and ForecastFree Investment Portfolio Suggestions - Autocar Professional
Investing in IT Sector Top Investment Strategy ToolsExplosive trading opportunities - jammulinksnews.com
SKF India Limited (SKFINDIA) Stock RalliesFree Trend-Following Techniques - jammulinksnews.com
Best Indian Stocks for Stable Returns Professional Trading PicksFree Predictions - jammulinksnews.com
Beta Bionics (BBNX) Drops 2.15% Despite Abbott Partnership - AInvest
Why Beta Bionics Inc. stock attracts strong analyst attentionFree Access to Community with 300% Return - Newser
How Beta Bionics Inc. stock performs during market volatilityFree Step-by-Step Investment Guide - Newser
What makes Beta Bionics Inc. stock price move sharplyLow Risk Scalping Alerts - Newser
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas - MSN
Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns - Benzinga
Beta Bionics, Inc. to Release Q2 2025 Financial Results on July 29, 2025 - Nasdaq
Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire
Tracking Blood Sugar: A Multi-Billion Dollar Industry's Remarkable Journey - Medical Device and Diagnostic industry
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Pump manufacturers: Patches are the fix for low AID uptake - BioWorld MedTech
ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors - MedTech Dive
BBNX Stock May Gain From Abbott Deal to Advance iLet Integration - Zacks Investment Research
Analysts expect Beta Bionics patch pump launch by 2027 - MassDevice
5 things to watch at the ADA’s Scientific Sessions - MedTech Dive
Beta Bionics Announces Agreement with Abbott to Integrate - GlobeNewswire
Global Artificial Pancreas Devices Market is Gearing Up for Outstanding Expansion at a CAGR of ~16% by 2032 | DelveInsight - GlobeNewswire Inc.
Beta Bionics (NASDAQ:BBNX) Now Covered by Truist Financial - Defense World
Beta Bionics initiated with a Buy at Truist - TipRanks
Beta Bionics, Inc.: Strategic Growth and Market Penetration with iLet Infusion Pump - TipRanks
Beta Bionics stock initiated with Buy rating at Truist Securities By Investing.com - Investing.com South Africa
Beta Bionics stock initiated with Buy rating at Truist Securities - Investing.com
Lake Street Capital Initiates Coverage on Beta Bionics (NASDAQ:BBNX) - Defense World
Beta Bionics, Inc. (NASDAQ:BBNX) Receives $23.13 Average Price Target from Brokerages - Defense World
Beta Bionics Executives Unload Shares in Major Stock Sell-Off! - TipRanks
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):